Concepedia

M. Lehnert

ML

Statistics

Publications

28

Citations

2.3K

H-Index

20

Active since

1991

Affiliations

Kantonsspital St. Gallen(Current)

University of Arizona

Mahidol University

National Cancer Centre Singapore

National University Hospital

M. Lehnert is an author at Kantonsspital St. Gallen specializing in medicine, cancer therapeutics, and oncology.

Top concepts

Publications per year

1991–2015

28

Publications

28

Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors

Amita Patnaik, Soonmo Peter Kang, Drew Rasco et al. · Clinical Cancer Research · 2015 · 767 citations

Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.

William T. Beck, Thomas M. Grogan, Cheryl L. Willman et al. · PubMed · 1996 · 387 citations

, , +18

High seroprevalence of Epstein–Barr virus in children with multiple sclerosis

Daniela Pohl, Bernd Krone, Kevin Rostásy et al. · Neurology · 2006 · 223 citations

Docetaxel and carboplatin is an active regimen in advancednon-small-cell lung cancer: a phase II study in Caucasian and Asian patients

Michael Millward, Michael Boyer, M. Lehnert et al. · Annals of Oncology · 2003 · 104 citations · Full text

, , +9

Synergistic inhibition by verapamil and quinine of P-glycoprotein- mediated multidrug resistance in a human myeloma cell line model

M. Lehnert, WS Dalton, Denise J. Roe et al. · Blood · 1991 · 85 citations · Full text

1–5 of 28